R&D Systems™ Recombinant Human LINGO-1 Protein

Catalog No.	Quantity
97-37L-G050	50 μg

Catalog No. 97-37L-G050 Supplier R&D Systems™ Supplier No. 9737LG050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its binding ability in a functional ELISA. When Biotinylated Recombinant Human Nogo Receptor Fc Chimera is present at 2.5 μg/mL, the concentration of Recombinant Human LINGO-1 that produces 50% of the optimal binding response is 0.4-2.4 μg/mL.

Specifications

• Accession Number: Q96FE5-1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 84894
• Molecular Weight (g/mol): M.W. (Observed): 82-112 kDa, reducing conditions; M.W. (theoretical): 60 kDa
• Name: FLJ14594, LERN1, LERN1UNQ201, leucine rich repeat and Ig domain containing 1, leucine rich repeat neuronal 6A, Leucine-rich repeat and immunoglobilin domain-containing protein 1, Leucine-rich repeat neuronal protein 1, Leucine-rich repeat neuronal protein 6A, LINGO1, LRRN6A, LRRN6Aleucine-rich repeat neuronal 6A, MGC17422
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human LINGO-1 protein Thr40-Thr556, with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, <= -20 °C as supplied. 2 weeks, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 1 mg/mL in PBS.
• Purity or Quality Grade: >80%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Protein: LINGO-1